William P. Petros, PharmD, a professor of pharmaceutical sciences, is the Gates Wigner Endowed Chair and dean of the WVU School of Pharmacy. He is also associate director of anti-cancer development and director of the clinical pharmacology and biospecimen processing cores at the WVU Cancer Institute.
Dr, Petros has published more than 100 articles in the areas of pharmacokinetics, pharmacogenomics, and early phase anti-cancer drug studies. He is a graduate of the WVU School of Pharmacy and earned his doctoral degree at the Philadelphia College of Pharmacy and Science. He completed research training at St. Jude Children’s Research Hospital.
He has been continually funded as a principal or co-investigator on National Institutes of Health private foundation and pharma cancer-related grants for more than 20 years.
Dr. Petros is an experienced cancer researcher who has served on a number of review committees for the National Institutes of Health and other national research organizations.
Hannah Hazard-Jenkins, MD
Director, WVU Cancer Institute; Director and Associate Chair of Surgery for Cancer Services, WVU Cancer Institute
Nathan Burt, MHA
Interim Vice President, WVU Cancer Institute; Vice President of Operations, J.W. Ruby Memorial Hospital
Deborah Falconi, MSN, RN, OCN
Assistant Vice President, Cancer Services Operation and Strategy, WVU Cancer Institute
Michael Ridinger, MBA, RN, BSN
Associate Director, WVU Cancer Institute; Administrator, WVU Section of Hematology/Oncology